http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-44718-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
filingDate 1996-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2002-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-44718-C2
titleOfInvention CRYSTAL FORM OF METHANSULPHONATE SALT 7 - ([1 <font face = "Symbol"> a </font>, 5 <font face = "Symbol"> a </font>, 6 <font face = "Symbol"> a </ font>] - 6-AMINO-3-AZABICYCLO [3.1.0] HEX-3-YL) -6-FLUORO-1- (2,4-DIFLUTORPHENYL) -1,4-DIHYDRO-4-OXO-1,8 -NAPHTHYRIDINE-3-CARBONIC ACID, METHOD OF ITS PRODUCTION, PHARMACEUTICAL COMPOSITION WITH ANTI-BACTERIAL ACTIVITY, TAPALOUS AND TAPASI
abstract Crystalline form of methanesulfonate salt 7 - ([1K, 5,, 6,] - 6-amino-3-azabicyclo [3.1.0] hex-3-yl) -6-fluoro-1- (2,4-difluorophenyl) - 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid. Pharmaceutical composition with antibacterial activity. The method of treatment consists in administering to the patient an amount of said compound in which it has an antibacterial effect. A method for obtaining a crystalline form is also described.
priorityDate 1995-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474469

Total number of triples: 30.